Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Statistical methods for cancer mutational signatures

$2.31M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization Dana-Farber Cancer Inst
Country United States
Start Date Jul 01, 2021
End Date Jun 30, 2026
Duration 1,825 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10662461
Grant Description

Project Summary Carcinogens and evolutionary pressures generate unique patterns in the types of somatic mutations observed in the DNA of cancer cells. Mutational signature analysis investigates these patterns. Following promising initial successes, the scope and variety of questions scientists ask in mutational signature analysis far exceed the

availability of robust data analytic tools to address them. The overarching goal of this project is to develop, test, and apply a class of statistical models able to compre- hensively support rigorous statistical inference on most of the important scienti?c questions arising in this novel ?eld. Speci?cally, we will generalize current approaches in fundamental ways to incorporate previously proposed

signatures, and account for multiple studies/conditions, covariates, paired/longitudinal data and batch effects. We will develop a comprehensive free and open-source R package, conforming to Bioconductor standards, al- lowing users to implement our analyses and their visualizations. Methods will leverage the investigative groups'

extensive experience in Bayesian modeling, multi-study modeling, multivariate analysis, and statistical genomics. Development will proceed hand in hand with discovery efforts within the Dana Farber multiple myeloma genomics program of which the PI is integral part. Given the fast growth in whole exome and whole genome sequencing of tumors, and the corresponding growth

in the use of mutational signature analysis, we expect our tools to have a substantial impact, by enabling cancer researchers to a) carry out more accurate analysis and b) more reliably evaluate the accuracy of their results. Thus we expect this work to substantially accelerate the rate of discovery and clinical translation of the biology of

mutational signatures in cancer.

All Grantees

Dana-Farber Cancer Inst

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant